UI 057
Alternative Names: UI-057Latest Information Update: 28 Jan 2022
At a glance
- Originator Korea United Pharm Inc
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Overactive bladder
Highest Development Phases
- Research Overactive bladder
Most Recent Events
- 17 Jan 2022 UI 057 is available for licensing as of 17 Jan 2022. https://www.kup.co.kr/research/innovation_main.htm (Korea United Pharm website, January 2022)
- 17 Jan 2022 Early research in Overactive bladder in South Korea (Inhalation) before January 2022 (Korea United Pharm pipeline, January 2022)
- 17 Jan 2022 Korea United Pharm plans to launch UI 057 for Overactive bladder (Inhalation, Controlled release) in 2024 (Korea United Pharm pipeline, January 2022)